Emerging In Vitro and In Vivo Models: Hope for the Better Understanding of Cancer Progression and Treatment
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This review explores various in vitro and in vivo cancer models, including mouse models, to understand tumor development and test anticancer drugs. These models are crucial for advancing cancer research and drug discovery.
Area Of Science
- Oncology
- Preclinical Research
- Drug Development
Background
- Cancer models are essential for understanding tumor development and evaluating anticancer drugs.
- Existing in vitro models are limited, necessitating more complex in vivo models.
- Accurate tumor microenvironment representation is key for effective preclinical studies.
Purpose Of The Study
- To review and summarize various in vitro and in vivo metastasis models in cancer research.
- To discuss the advantages and disadvantages of different cancer models.
- To highlight the role of these models in advancing cancer drug development.
Main Methods
- Overview of in vitro models (transwell, spheroids, CRISPR-Cas9).
- Presentation of in vivo models, primarily mouse models.
- Discussion of model complexity and relevance to tumor microenvironment.
Main Results
- In vitro models are foundational but limited in complexity.
- In vivo mouse models offer genetic manipulability and rapid tumor growth.
- Advanced models are needed to mimic tumor complexity and microenvironment.
Conclusions
- Both in vitro and in vivo models are vital tools in cancer research.
- Mouse models are effective for studying human cancers due to biological similarities.
- The choice of model impacts target validation, drug response, and toxicity studies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
